On May 15th the U.S. House Committee on Oversight and Accountability voted to approve the BIOSECURE Act, which now goes to the Senate for approval. As the BIOSECURE Act advances in congress that would restrict U.S. business with certain Chinese biotechnology companies, it now provides U.S. companies until 2032 to find new service providers.    The latest revisions to the bill add WuXi Biologics to a list of biotech companies of concern, according to a copy seen by Reuters. Other companies on t...